Tetrahydrobiopterin and inherited hyperphenylalaninemias

Turkish Journal of Pediatrics

Volumn 38, Issue 1, 1996, Pages 19-35

  Blau, Nenad ^a   Thöny, Beat ^a   Spada, Marco ^b   Ponzone, Alberto ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Biopterin; Genetics; Hyperphenylalaninemia; Neonatal screening; Neopterin; Phenylalanine; Phenylketonuria; Tetrahydrobiopterin

Indexed keywords

5,6,7,8-TETRAHYDROBIOPTERIN; BIOPTERIN; DIHYDROPTERIDINE REDUCTASE; DRUG DERIVATIVE; PHENYLALANINE; PTERIN DERIVATIVE; TETRAHYDROBIOPTERIN;

BLOOD; ENZYMOLOGY; GENETICS; HUMAN; INBORN ERROR OF METABOLISM; METABOLISM; NEWBORN; PROGNOSIS; REVIEW; URINE;

BIOPTERIN; DIHYDROPTERIDINE REDUCTASE; HUMANS; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; PHENYLALANINE; PROGNOSIS; PTERINS;

EID: 0029681568     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. Scriver CR, Eisensmith RC, Woo SLC, et al. The hyperphenylalaninemias of man and mouse. Annu Rev Genet 1994; 28: 141-165.
2. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993; 268: 12231-12234.
3. Kaufman S, Pollock RJ, Summer GK, Das AK, Hajra AK. Dependence of an alkyl glycolether monooxygenase activity upon tetrahydropterins. Biochim Biophys Acta 1990; 1040: 19-27.
4. Tanaka K, Kaufman S, Milstien S. Tetrahydrobiopterin, the cofactor for aromatic amino acid hydroxylases, is synthesized by and regulates proliferation of erythroid cells. Proc Natl Acad Sci USA 1989; 86: 5864-5867.
5. Koshimura K, Miwa S, Lee K, Fujiwara M, Watanabe Y. Enhancement of dopamine release in vivo from the rat striatum by dialytic perfusion of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin. J Neurochem 1990; 54: 1391-1397.
6. Nichol CA, Smith GK, Duch DS. Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu Rev Biochem 1985; 54: 729-764.
7. Curtius CH, Heintel D, Ghisla S, Kuster TH, Leimbacher W, Niederwieser A. Biosynthesis of tetrahydrobiopterin in man. J Inherit Metab Dis 1985; 8: 28-33.
8. Duch DS, Smith GK. Biosynthesis and function of tetrahydrobiopterin. J Nutr Biochem 1991; 2: 411-423.
9. Kaufman S. New tetrahydrobiopterin-dependent systems. Annu Rev Nutr 1993; 13: 261-286.
10. Blau N, Niederwieser A. GTP-cyclohydrolases: a review. J Clin Chem Clin Biochem 1985; 23: 169-176.
11. Harada T, Kagamiyama H, Hatakeyama K. Feedback regulation mechanisms for the control of GTP cyclohydrolase I activity. Science 1993; 260: 1507-1510.
12. Ponzone A, Guardamagna O, Spada M, et al. Hyperphenylalaninemia and pterin metabolism in serum and erythrocytes. Clin Chim Acta 1993; 216: 63-71.
13. Takikawa SI, Curtius CH, Redweik U, Leimbacher W, Ghisla S. Biosynthesis of tetrahydrobiopterin. Purification and caharacterization of 6-pyruvoyl-tetrahydropterin synthase from human liver. Eur J Biochem 1986; 161: 295-302.
14. Bürgisser D, Thöny B, Redweik U, et al. 6-pyruvoyl tetrahydropterin synthase, an enzyme with a novel type of active site involving both zinc binding and an intersubunit catalytic triad motif; Site-directed mutagenesis of the proposed active center, characterization of the metal binding site and modelling of substrate binding. J Mol Biol 1995; 253: 358-369.
15. Oppliger T, Thöny B, Nar H, et al. Structural and functional consequences of mutations in 6-pyruvoyl tetrahydropterin synthase causing hyperphenylalaninemia in humans. J Biol Chem 1995; 270: 1-9.
16. Ichinose H, Ohye T, Matsuda Y, et al. Characterization of mouse and human GTP cyclohydrolase I genes-Mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem 1995; 270: 10062-10071.
17. Smith GK. On the role of sepiapterin reductase in the biosynthesis of tetrahydrobiopterin. Arch Biochem Biophys 1987; 255: 254-266.
18. Lazarus RA, Benkovic SJ, Kaufman S. Phenylalanine hydroxylase stimulator protein is a 4a-carbinolamine dehydratase. J Biol Chem 1983; 258: 10960-10962.
19. Rebrin I, Bailey SW, Boerth SR, Ardell MD, Ayling JE. Catalytic characterization of 4a-hydroxytetrahydropterin dehydratase. Biochemistry 1995; 34: 5801-5810.
20. Köster S, Thöny B, Macheroux P, et al. Human pterin-4a-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1-alpha: characterization and kinetic analysis of wild-type and mutant enzymes. Eur J Biochem 1995; 231: 414-423.
21. Kaufman S. A protein that stimulates rat liver phenylalanine hydroxylase. J Biol Chem 1970; 254: 4751-4759.
22. Curtius HC, Matasovic A, Schoedon G, et al. 7-Substituted pterins. A new class of mammalian pteridines. J Biol Chem 1990; 265: 3923-3930.
23. Citron BA, Davis MD, Milstien S, et al. Identity of 4a-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. Proc Natl Acad Sci USA 1992; 89: 11891-11894.
24. Hauer CR, Rebrin I, Thöny B, et al. Phenylalanine hydroxylase-stimulating protein/pterin-4alpha-carbinolamine dehydratase from rat and human liver. Purification, characterization, and complete amino acid sequence. J Biol Chem 1993; 268: 4828-4831.
25. Mendel DB, Khavari PA, Conley PB, et al. Characterization of a cofactor that regulates dimerization of mammalian homeodomain protein. Science 1991; 254: 1762-1767.
26. Netter JC, Dhondt JL, Rance F, Petrus M. Early neurotoxicity of high-dose of methotrexate and tetrahydrobiopterin deficiency. Arch Fr Pediatr 1991; 48: 719-722.
27. Tada K, Yoshida T, Mochizuki K, et al. Two siblings of hyperphenylalaninemia: suggestion to a genetic variant of phenylketonuria. Tohoku J Exp Med 1969; 100: 249-253.
28. Tada K, Narisawa K, Aral N, Ogasawara Y, Ishizawa S. A sibling case of hyperphenylalaninemia due to a deficiency of dihydropteridine reductase: biochemical and pathological findings. Tohoku J Exp Med 1980; 132: 123-131.
29. Smith I. Atypical phenylketonuria accompanied by a severe progressive neurological illness unresponsive to dietary treatment. Arch Dis Child 1974; 49: 245.
30. Bartholomé K. A new molecular defect in phenylketonuria. Lancet 1974; 2: 1580.
31. Smith I, Clayton BE, Wolff OH. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction. Lancet 1975; 1: 1108-1111.
32. Bartholomé K, Byrd DJ, Kaufman S, Milstien S. Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro. Pediatrics 1977; 59: 757-761.
33. Bartholomé K, Lutz P, Bickel H. Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia. Pediatr Res 1975; 9: 899-903.
34. Brewster TG, Abroms IF, Kaufman S, et al. Atypical PKU; seizures, and developmental delay with dihydropteridine reductase deficiency. Pediatr Res 1976; 10: 446.
35. Butler IJ, Holtzman NA, Kaufman S, Koslow SH, Krumholz A. Phenylketonuria due to deficiency of dihydropteridine reductase. Pediatr Res 1975; 9: 349.
36. Danks DM, Cotton RGH, Schlesinger P. Tetrahydrobiopterin treatment of variant form of phenylketonuria. Lancet 1975; 2: 1043.
37. Danks DM, Cotton RGH, Schlesinger P. Variant forms of phenylketonuria. Lancet 1976; 1: 1236-1237.
38. Kaufman S, Milstien S, Bartholomé K. New forms of phenylketonuria. Lancet 1975; 2: 708.
39. Rey F, Blandin-Savoja F, Rey J. Atypical phenylketonuria with normal dihydropteridine reductase activity. N Engl J Med 1976; 295: 1138-1139.
40. Danks DM. Pteridines and phenylketonuria: report of a workshop: introductory comments. J Inherit Metab Dis 1978; 1: 47-48.
41. Danks DM, Schlesinger P, Firgaira et al. Malignant hyperphenylalaninemia-clinical features, biochemical findings, and experience with administration of biopterins. Pediatr Res 1979, 13: 1150-1155.
42. Bartholomé K, Byrd DJ. L-dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine-hydroxylase activity. Lancet 1975; 2: 1042-1043.
43. Butler IJ, O'-Flynn ME, Seifert WE, Howell RR. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia. J Pediatr 1981; 98: 729-733.
44. Endres W, Niederwieser A, Curtius HCH, Wang M, Ohrt B, Schaub J. Atypical phenylketonuria due to biopterin deficiency. Early treatment with tetrahydrobiopterin and neurotransmitter precursors, trials of monotherapy. Helv Paediatr Acta 1982; 37: 489-498.
45. Endres W, Niederwieser A, Curtius HCH, Ohrt B, Schaub J. Dihydrobiopterin deficiency: monotherapy with tetrahydrobiopterin (BH4) and diacetyl BH4. Pediatr Res 1982; 16: 694.
46. Kaufman S, Kapatos G, McInnes RR, Schulman JD, Rizzo WR. Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain. Pediatrics 1982; 70: 376-380.
47. McInnes RR, Kaufman S, Warsh JJ, et al. Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin. J Clin Invest 1984; 73: 458-469.
48. Niederwieser A, Curtius HCH, Wang M, Leupold D. Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man. Eur J Pediatr 1982; 138: 110-112.
49. Schaub J, Daumling S, Curtius HCH, et al. Tetrahydrobiopterin therapy of atypical phenylketonuria due to defective dihydrobiopterin biosynthesis. Arch Dis Child 1978; 53: 674-676.
50. Dhondt JL. Tetrahydrobiopterin deficiencies: preliminary analysis from an international survey. J Pediatr 1984; 104: 501-508.
51. Blau N, Thöny B, Heizmann CW, Dhonat JL. Tetrahydrobiopterin deficiency: from phenotype to genotype. Pteridines 1993; 4: 1-10.
52. Blau N, Barnes I, Dhondt JL International database of tetrahydrobiopterin deficiencies. J Inherit Metab Dis 1996 (in press).
53. Blau N. Guidelines for the screening for hyperphenylalaninemia due to tetrahydrobiopterin deficiency. Cro Med J 1992; 33: 17-22.
54. Dhondt JL. Strategy for the screening of tetrahydrobiopterin deficiency among hyperphenylalaninaemic patients: 15-years experience. J Inherit Metab Dis 1991; 14: 117-127.
55. Blau N, Kierat L, Heizmann CW, Endres W, Giudici T, Wang M. Screening for tetrahydrobiopterin deficiency in newborns using dried urine on filter paper. J Inherit Metab Dis 1992; 15: 402-404.
56. Niederwieser A, Curtius HCH, Viscontini M, Schaub J, Schmidt H. Phenylketonuria variants. Lancet 1979; 1: 550.
57. Lipson A, Yu J, O Halloran M, Potter M, Wilken B. Dihydropteridine reductase deficiency: non-response to oral tetrahydrobiopterin load test. J Inherit Metab Dis 1984; 7: 69-71.
58. Cotton RGH, Jennings I, Bracco G, Panzone A, Guardamagna O. Tetrahydrobiopterin non-responsiveness in dihydropteridine reductase deficiency is associated with the presence of mutant protein. J Inherit Metab Dis 1986; 9: 239-243.
59. Ponzone A, Guardamagna O, Spada M, et al. Differential diagnosis of hyperphenylalaninemia by a combined phenylalanine-tetrahydrobiopterin loading test. Eur J Pediatr 1993; 152: 655-661.
60. Shintaku H, Niederwieser A, Leimbacher W, Curtius HCH. Tetrahydrobiopterin deficiency: assay for 6-pyruvoyl-tetrahydropterin synthase activity in erythrocytes, and detection of patients and heterozygous carriers. Eur J Pediatr 1988; 147: 15-19.
61. Arai N, Narisawa K, Hayakawa H, Tada K. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots. Pediatrics 1982; 70: 426-430.
62. Blau N, Niederwieser A. Guanosine triphosphate cyclohydrolase-l assay in human and rat liver using high-performance liquid chromatography of neopterin phosphates and guanine nucleotides. Anal Biochem 1983; 128: 446-452.
63. Blau N, Joller P, Atarés M, Cardesa-Garcia J, Niederwiesser A. Increase of GTP cyclohydrolase-I activity in mononuclear blood cells by stimulation: detection of heterozygotes of GTP cyclohydrolase-1 deficiency. Clin Chim Acta 1985; 148: 47-52.
64. Werner ER, Werner Felmayer G, Fuchs D, HausenA, Reibnegger G, Wachter H. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem J 1989; 262: 861-866.
65. Milstienn S, Kaufman S, Sakai N, Tetrahydrobiopterin biosynthesis defects examined in cytokine-stimulated fibroblasts. J Inherit Metab Dis 1993; 16: 975-981.
66. Dhondt JL, Guibaud P, Rolland MO, et al. Neonatal hyperphenylalaninaemia presumably caused by a new variant of biopterin synthetase deficiency. Eur J Pediatr 1988; 147: 153-157.
67. Blaskovics M, Giudici TA. A new variant of biopterin deficiency. N Engl J Med 1988, 319: 1611-1612.
68. Dhondt JL. Tetrahydrobiopterin deficiencies: lessons from the compilation of 200 patients. Dev Brain Dysfunct 1993; 139: 141-157.
69. Hyland K. Abnormalities of biogenic amine metabolism. J Inherit Metab Dis 1993; 16: 676-690.
70. Smith I, Dhondt JL. Birthweight in patients with defective biopterin metabolism. Lancet 1985; 1: 818.
71. Ponzone A, Ferroro GB, Guardamagna O, Ferroris S, Curtius HCH, Blau N. Screening and treatment of tetrahydrobiopterin deficiency. In: Curtius HC, Ghisla S, Blau N (eds). Chemistry and Biology of Pteridines 1989. Berlin: Walter de Gruyter, 1990: 393-401.
72. Coşkun T, Besim A, Özalp I, et al. Intracranial calcification in dihydropteridine reductase deficiency. Turk J Pediatr 1990; 32: 259-264.
73. Woody RC, Brewster MA, Glasier C. Progressive intracranial calcification in dihydropteridine reductase deficiency prior to folinic acid therapy. Neurology 1989; 39: 673-675.
74. Biasucci G, Valsasina R, Giovannini M, Brioschi M, Saleri L, Riva E. Neuroradiological improvement after one year of therapy in a case of DHPR deficiency. In Curtius HC, Ghisla S, Blau N (eds). Chemistry and Biology of Pteridines 1989. Berlin: Walter de Gruyter, 1990: 438-444.
75. Ponzone A, Guardamagna O, Ferraris S, Biasetti S, Bracco G, Niederwieser A. Neurotransmitter therapy and diet in malignant phenylketonuria. Eur J Pediatr 1987; 146: 93-94.
76. Ponzone A, Guardamagna O, Dianzani I, et al. Catalytic activity of tetrahydrobiopterin in dihydropteridine reductase deficiency and indications for treatment. Pediatr Res 1993; 33: 125-128.
77. Ponzone A, Biasetti S, Ferraris S, et al. Differential entrance of tetrahydrobiopterin into the brain of patients with 6-pyruvoyl tetrahydropterin synthase deficiency. In: Levine RA, Milstien S, Kuhn DM, et al (eds). Pterins and Biogenic Amines in Neuropsychiatry, Pediatrics and Immunology. Grosse Pointe: Lakeshore Publishing Co, 1989: 325-334.
78. Kapatos G, Kaufman S. Peripherally administered reduced pterins do enter the brain. Science 1981; 212: 955-956.
79. Leupold D. Tetrahydrobiopterin monotherapy in two siblings wtih dihydrobiopterin deficiency. In Wachter H, Curtius HC, Pfleiderer W (eds). Biochemical and Clinical Aspects of Pteridines. Berlin: Walter de Gruyter, 1982: 307-317.
80. Giugliani R, Costa da-Costa J, Dutra-Filho CS, et al. Successful therapy of hyperphenylalaninemia due to defective tetrahydrobiopterin metabolism in two siblings. Rev Brasil Genet 1986; 9: 685-692.
81. Snyderman SE, Sansaricq C, Pulmones MT. Successful long term therapy of biopterin deficiency. J Inherit Metab Dis 1987; 10: 260-266.
82. Endres W, Blau N, Curtius HC. Newborn screening and treatment of hyperphenylalaninemia due to tetrahydrobiopterin deficiency. In: Schmidt BJ, Diamenti AJ, Loghin-Grosso NS (eds). Current Trends in Infant Screening. Amsterdam: Excerpta Medica, 1989: 77-82.
83. Endres W. Differential diagnosis and therapy of various forms of hyperphenylalaninemia: facts and fiction. Wien Klin Wochenschr 1992, 104: 503-509.
84. Tanaka Y, Matsuo N, Tsuzak S, Araki K, Tsuchiya Y, Niederwieser A. On-off phenomenon in a child with tetrahydrobiopterin deficiency due to 6-pyruvoyl tetrahydropterin synthase deficiency (BH4 deficiency). Eur J Pediatr 1989; 148: 450-452.
85. Schuler A, Blau N, Ponzone A. Monoamine oxidase inhibitors in tetrahydrobiopterin deficiency. Eur J Pediatr, 1995 (in press).
86. Coşkun T, Özalp I, Tokatli A, Blau N, Niederwieser A. Hyperphenylalaninemia due to tetrahydrobiopterin deficiency. A report of 16 cases. J Inherit Metab Dis 1993; 16: 605-607.
87. Hsiao KJ, Chiang SH, Liu TT, Chiu PC, Wuu KT. Tetrahydrobiopterin deficient phenylketonuria detected by neonatal screening in Taiwan. In: Curtius HC, Ghisla S, Blau N (eds). Chemistry and Biology of Pteridines 1989. Berlin: Walter de Gruyter 1990: 402-407.
88. Al-Aqeel A, Ozand PT, Gascon G, et al. Biopterin-dependent hyperphenylalaninemia due to deficiency of 6-pyruvoyl tetrahydropterin synthase. Neurology 1991; 41: 730-737.
89. Al-Aqeel A, Ozand PT, Gascon G, et al. Response of 6-pyruvoyl-tetrahydropterin synthase deficiency to tetrahydrobiopterin. J Child Neurol 1992; 7 (Suppl): 526-530.
90. Thöny B, Heizmann CW, Mattei MG. Chromosomal localization of two human genes encoding tetrahydrobiopterin-metabolizing enzymes: 6-pyruvoyl-tetrahydropterin synthase maps to 11q22.3-q23.3 and pterin-4a-carbinolamine dehydratase maps to 10q22. Genomics 1994; 19: 365-368.
91. Thöny B, Heizmann CW, Mattei MG. Human GTP cyclohydrolase I gene and sepiapterin reductase gene map to region 14q21-q22 and 2p14-p12, respectively, by in situ hibridization. Genomics 1995; 20: 168-170.
92. Brown RM, Dahl HH. Localization of the human dihydropteridine reductase gene to band p15.3 of chromosome 4 by in situ hybridization. Genomics 1987; 1: 67-70.
93. Thöny B, Neuheiser F, Blau N, Heizmann CW. Characterization of the human PCBD gene encoding the bifunctional protein pterin-4α-carbinolamine dehydratase/dimerization cofactor for the transcription factor HNF-1α. Biochem Biophys Res Commun 1995; 210: 966-973.
94. Blau N, Ichinose H, Nagatsu T, Heizmann CW, Zacchello F, Burlina B. A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program. J Pediatr 1995; 126: 401-405.
95. Thöny B, Leimbacher W, Blau N, Harvie A, Heizmann CW. Hyperphenylalaninemia due to defects in tetrahydrobiopterin metabolism: molecular characterization of mutations in 6-pyruvoyl-tetrahydropterin synthase. Am J Hum Genet 1994; 54: 782-792.
96. Imamura T, Okano Y, Sawada Y, et al. A missense mutation of 6-pyruvoyl-tetrahydropterin synthase deficiency in Japanese. Pteridines 1994; 5: 31.
97. Ashida A, Owada M, Hatakeyama K. A missense mutation (A to G) of 6-pyruvoyltetrahydropterin synthase in tetrahydrobiopterin-deficient form of hyperphenylalaninemia. Genomics 1994; 24: 408-410.
98. Oppliger T, Thöny B, Leimbacher W, et al. Mutation analysis in patients with 6-pyruvoyltetrahydropterin synthase deficiency. Pteridines 1995; 6: 141-143.
99. Smooker PM, Cotton RGH. Molecular basis of dihydropteridine reductase deficiency. Hum Mutat 1995; 5: 279-284.
100. Smooker PM, Howells DW, Dianzani I, Cotton RGH. The spectrum of mutations in dihydropteridine reductase deficiency. In: Ayling JE, Nair MG, Baugh CM (eds). Chemistry and Biology of Pteridines and Folates. New York: Plenum Press, 1993: 135-138.
101. Blau N, Heizmann CW, Sperl W, et al. Atypical (mild) forms of dihydropteridine reductase deficiency: neurochemical evaluation and mutation detection. Pediatr Res 1992; 32: 726-730.
102. Citron BA, Kaufman S, Milstien S, Naylor EW, Greene CL, Davis MD. Mutation in the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalaninemia with defective cofactor metabolism. Am J Hum Genet 1993; 53: 768-774.